{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:33:07Z","timestamp":1791462787502,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["ENDO-2021-12371926"],"award-info":[{"award-number":["ENDO-2021-12371926"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijgc.2025.101990","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T19:15:11Z","timestamp":1750878911000},"page":"101990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mesonephric-like adenocarcinoma of the ovary: features of a rare and aggressive entity associated with endometriosis"],"prefix":"10.1016","volume":"36","author":[{"given":"Francesco","family":"Mezzapesa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Giunchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"De Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8393-1799","authenticated-orcid":false,"given":"Dondi","family":"Giulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Di Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7802-8261","authenticated-orcid":false,"given":"Lucia","family":"Genovesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0609-8817","authenticated-orcid":false,"given":"Dario","family":"De Biase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8841-6531","authenticated-orcid":false,"given":"Pierandrea","family":"De Iaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3140-4772","authenticated-orcid":false,"given":"Anna Myriam","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijgc.2025.101990_bib1","series-title":"Female Genital Tumours WHO Classification of Tumours","year":"2020"},{"issue":"7","key":"10.1016\/j.ijgc.2025.101990_bib2","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/his.12895","article-title":"Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas","volume":"68","author":"McFarland","year":"2016","journal-title":"Histopathology"},{"issue":"21","key":"10.1016\/j.ijgc.2025.101990_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192114451","article-title":"Mesonephric-like adenocarcinomas a rare tumor: the importance of diagnosis","volume":"19","author":"Restaino","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101990_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.6217","article-title":"Mesonephric-like adenocarcinoma harbours characteristic copy number variations and a distinct DNA methylation signature closely related to mesonephric adenocarcinoma of the cervix","volume":"262","author":"Kommoss","year":"2024","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101990_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pathol.2017.11.084","article-title":"Mesonephric proliferations of the female genital tract","volume":"50","author":"Howitt","year":"2018","journal-title":"Pathology"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101990_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13000-019-0830-4","article-title":"Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a M\u00fcllerian duct lineage: a case report","volume":"14","author":"Yano","year":"2019","journal-title":"Diagn Pathol"},{"issue":"6","key":"10.1016\/j.ijgc.2025.101990_bib7","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1177\/10668969231213390","article-title":"Mixed mesonephric-like adenocarcinoma, clear cell carcinoma, and endometrioid carcinoma arising from an endometriotic cyst","volume":"32","author":"Nagase","year":"2024","journal-title":"Int J Surg Pathol."},{"issue":"1","key":"10.1016\/j.ijgc.2025.101990_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/PGP.0000000000000863","article-title":"Two cases of mesonephric-like carcinoma arising from endometriosis: case report and review of the literature","volume":"42","author":"Chang","year":"2023","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ijgc.2025.101990_bib9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ygyno.2024.01.015","article-title":"Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: a single-center experience with molecular characterization, treatment, and oncologic outcomes","volume":"182","author":"Praiss","year":"2024","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ijgc.2025.101990_bib10","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.3390\/curroncol31090378","article-title":"Ovarian mesonephric-like adenocarcinoma: its prevalence in a Japanese high-volume cancer center and a literature review on therapeutic targets","volume":"31","author":"Ogawa","year":"2024","journal-title":"Curr Oncol"},{"issue":"6","key":"10.1016\/j.ijgc.2025.101990_bib11","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/his.12332","article-title":"Thyroid transcription factor-1 (TTF\u22121) immunoreactivity is an adverse prognostic factor in endometrioid adenocarcinoma of the uterine corpus","volume":"64","author":"Ervine","year":"2014","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.ijgc.2025.101990_bib12","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/his.15393","article-title":"Papillary and ductal patterns of mesonephric-like adenocarcinomas are often overlooked: a retrospective revaluation of over 1000 endometrial carcinomas","volume":"86","author":"Akbari","year":"2025","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101990_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/2056-4538.12389","article-title":"Mesonephric-type adenocarcinomas of the ovary: prevalence, diagnostic reproducibility, outcome, and value of PAX2","volume":"10","author":"K\u00f6bel","year":"2024","journal-title":"J Pathol Clin Res"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101990_bib14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/PAS.0000000000001612","article-title":"Clinicopathologic characteristics of mesonephric adenocarcinomas and mesonephric-like adenocarcinomas in the gynecologic tract: a multi-institutional study","volume":"45","author":"Pors","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.101990_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2025.101638","article-title":"Controversies in the management of mesonephric and mesonephric-like adenocarcinomas of the female Genital Tract","volume":"35","author":"Praiss","year":"2025","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.ijgc.2025.101990_bib16","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1046\/j.1469-0705.2000.00287.x","article-title":"Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) group","volume":"16","author":"Timmerman","year":"2000","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101990_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ygyno.2007.05.032","article-title":"A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model","volume":"107","author":"Aletti","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101990_bib18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ijgc.2025.101990_bib19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.annonc.2023.11.015","article-title":"ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease","volume":"35","author":"Ledermann","year":"2024","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.ijgc.2025.101990_bib20","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1136\/ijgc-2022-004249","article-title":"Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma","volume":"33","author":"Perrone","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.ijgc.2025.101990_bib21","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.3802\/jgo.2023.34.e82","article-title":"Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and overall survival","volume":"34","author":"Coada","year":"2023","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101990_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archsurg.1925.01120100007001","article-title":"Endometrial carcinoma of the ovary arising in endometrial tissue in that organ","volume":"10","author":"Sampson","year":"1925","journal-title":"Arch Surg"},{"issue":"3","key":"10.1016\/j.ijgc.2025.101990_bib23","first-page":"283","article-title":"Malignant changes in endometriosis","volume":"2","author":"Scott","year":"1953","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101990_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/PGP.0000000000000952","article-title":"Atypical Endometriosis: comprehensive Characterization of Clinicopathologic, immunohistochemical, and Molecular Features","volume":"43","author":"Wepy","year":"2023","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.101990_bib25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2014.04.013","article-title":"2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer","volume":"133","author":"Mutch","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101990_bib26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/PAS.0000000000001401","article-title":"Mesonephric-like carcinoma of the endometrium: a subset of endometrial carcinoma with an aggressive behavior","volume":"44","author":"Euscher","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101990_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2025.101634","article-title":"Two possible entities of endometriosis-associated ovarian cancer: correlated or incidental?","volume":"35","author":"Mezzapesa","year":"2025","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijgc.2025.101990_bib28","article-title":"Mesonephric-like adenocarcinoma arising from endometrioid adenofibroma in a patient with in-utero exposure to diethylstilbestrol: a case report","volume":"39","author":"Linck","year":"2023","journal-title":"Case Rep Womens Health"},{"issue":"5","key":"10.1016\/j.ijgc.2025.101990_bib29","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/PGP.0000000000000444","article-title":"An ovarian adenocarcinoma with combined low-grade serous and mesonephric morphologies suggests a M\u00fcllerian origin for some mesonephric carcinomas","volume":"37","author":"Chapel","year":"2018","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"10.1016\/j.ijgc.2025.101990_bib30","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jama.2024.9210","article-title":"Endometriosis typology and ovarian cancer risk","volume":"332","author":"Barnard","year":"2024","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.ijgc.2025.101990_bib31","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1917239","article-title":"KRAS G12C inhibition with sotorasib in advanced solid tumors","volume":"383","author":"Hong","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ijgc.2025.101990_bib32","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/s41379-021-00799-6","article-title":"Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases","volume":"34","author":"da Silva","year":"2021","journal-title":"Mod Pathol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25011107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25011107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:31:01Z","timestamp":1776346261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X25011107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1048891X25011107"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.101990","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesonephric-like adenocarcinoma of the ovary: features of a rare and aggressive entity associated with endometriosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.101990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101990"}}